FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3771530 · Received April 24, 2014

Report

Report Number
2124215-2014-09147
Event Type
Malfunction
Date Received
April 24, 2014
Date of Event
March 10, 2014
Report Date
March 10, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT TACHYCARDIA THERAPY FOR THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS PROGRAMMED TO OTHER THAN MONITOR PLUS THERAPY FOR AN UNKNOWN REASON. ATTEMPTS AT ACQUIRING ADDITIONAL INFORMATION HAVE BEEN UNSUCCESSFUL. THE DEVICE REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
249096 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 83 YR 0184| 1861| E110| 0158| 4470